Stock screenerAll disclosures →
EDGAR →
AVTX
Conviction 90HealthcareScan · Mon, Jul 20, 2026AVTX$18.22-5.94%
ResistanceSupportVol 14Insider sell16
Vol MA14 1.49M
Apr 20May 6May 26Jun 11Jul 1Jul 20
Price18.22
Change-5.94%
Gap+0.13%
Rel volume1.91×
Avg volume1.93M
Avg $ vol35.48M
SMA 2018.61
SMA 5017.11
SMA 20016.30
Price vs 50+6.52%
Price vs 200+11.81%
MA stackbullish
50/200 cross—
Supertrendup · 15.82
RSI (14)52
MACD hist-0.14
MACD crossbear · 3d
Stoch %K / %D29 / 37
ADX (14)21
+DI / −DI22 / 16
RSI divergence—
MACD divergence—
ATR %+7.26%
ADR %7.47%
52w high22.87
52w low6.25
From 52w high-20.33%
Above 52w low+191.52%
New 52w highNo
SqueezeOff
Bollinger width16.73%
%B0.38
Donchian pos59.09%
Donchian high20.65
Donchian low14.71
AVWAP (52w high)17.50
vs AVWAP high+4.12%
AVWAP (52w low)16.61
vs AVWAP low+9.68%
OBV trendUp
Chaikin MF (20)0.02
Today vs 20d1.91×
Avg vol (14d)1.49M
Avg vol (20d)1.93M
Avg $ vol (20d)35.48M
Market cap957.74M
RS 3m (vs SPY)+28.39%
RS 6m (vs SPY)+11.97%
RS line new highNo
Trend template6/8
Technical rank80.8
1 week-3.65%
1 month+18.31%
3 months+26.26%
6 months+16.50%
1 year+221.91%
YTD+7.05%
P/E-12.24
P/B14.02
P/S—
P/FCF-18.58
EPS-5.84
Div yield—
ROE-114.55%
ROA-78.35%
Debt/Eq0.22
Current7.66
EV/EBITDA-13.06
Gross margin—
Net margin—
Rev growth-86.62%
EPS growth-122.78%
Price target44.90
Target upside146.43%
Analyst ratingBuy
Institutional61.67%
Ent. value948.06M
Revenue0
Net income-19.63M
Gross profit—
Free cash flow-51.55M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out52.57M
Employees33
ListedFri, Nov 13, 2015
Free float21.22M
Float %86.6%
Short interest12.31M
Days to cover4.3d
Short volume83.5%
Squeeze score95 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.98 vs −$1.00
Last surprise+2.0% beat
Setup gradeA+
Conviction90 / 100
Pattern quality—
Tech rank80.8 / 100
Group rank23 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance20.55
Support13.90
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in AVTX
No recent disclosed trades by Congress in AVTX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in AVTX · 4 buys · 6 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Doyle Mittie Chief Medical Officer · Common Stock · 2026-06-23 | Sell | 1.45K | $26K | 2026-06-23 | 2026-06-25 |
Doyle Mittie Chief Medical Officer · Common Stock · 2026-06-23 | Exercise | 1.45K | $12K | 2026-06-23 | 2026-06-25 |
Doyle Mittie Chief Medical Officer · Stock Option (Right to Buy) · 2026-06-23 | Exercise | 1.45K | — | 2026-06-23 | 2026-06-25 |
Philip Ron M Director · Stock Option (Right to Buy) · 2026-06-23 | Grant | 40.2K | — | 2026-06-23 | 2026-06-25 |
VARKI PAUL Chief Legal Officer · Common Stock · 2026-06-10 | Tax | 1.08K | $14K | 2026-06-10 | 2026-06-12 |
Sullivan Christopher Ryan Chief Financial Officer · Common Stock · 2026-06-10 | Tax | 138 | $2K | 2026-06-10 | 2026-06-12 |
Doyle Mittie Chief Medical Officer · Common Stock · 2026-06-10 | Tax | 1.08K | $14K | 2026-06-10 | 2026-06-12 |
Riley Jennifer Chief Strategy Officer · Common Stock · 2026-06-10 | Tax | 588 | $8K | 2026-06-10 | 2026-06-12 |
Jain Rita Director · Stock Option (Right to Buy) · 2026-06-02 | Grant | 20.1K | $0 | 2026-06-02 | 2026-06-04 |
KANTOFF AARON Director · Stock Option (Right to Buy) · 2026-06-02 | Grant | 20.1K | $0 | 2026-06-02 | 2026-06-04 |
SEC filings
EDGAR filings in AVTX · 9 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.